J Appl Biomed 2:51-56, 2004

Synthesis of the three monopyridinium oximes and evaluation of their potency to reactivate acetylcholinesterase inhibited by nerve agents

Kamil Kuča1,*, Jan Pícha2, Jiří Cabal1, František Liška2
1 Purkyně Military Medical Academy, Department of Toxicology, 500 01 Hradec Králové, Czech Republic
2 Institute of Chemical Technology, Department of Organic Chemistry, 166 28 Praha 6, Czech Republic

Three potential reactivators of nerve agents-inhibited acetylcholinesterase: 2-[(hydroxyimino)phenylmethyl]-1-methylpyridinium iodide

3a, 2-[(hydroxyimino)pyridin-2-ylmethyl]-1-methylpyridinium iodide

3b and 2-[(1-hydroxyimino) ethyl]-1-methylpyridinium iodide

3c were synthesized. Their reactivation potency was examined using a standard in vitro reactivation test. A rat brain homogenate was used as the source of acetylcholinesterase. Their reactivation potency was compared with a currently used acetylcholinesterase reactivator - 2-PAM (pralidoxime)

4. All tested reactivators were less effective acetylcholinesterase reactivators compared to 2-PAM. In this study, we also tested the reactivation potency of the oxime 2-PAM against inhibition of acetylcholinesterase by sarin, cyclosarin, VX and tabun. Satisfactory results are shown only for the reactivation sarin- and VX-inhibited acetylcholinesterase.

Keywords: VX; reactivation; acetylcholinesterase; oximes; sarin; tabun; cyclosarin

Received: May 23, 2003; Revised: October 3, 2003; Published: March 31, 2004  Show citation

ACS AIP APA ASA Harvard Chicago Chicago Notes IEEE ISO690 MLA NLM Turabian Vancouver
Kuča K, Pícha J, Cabal J, Liška F. Synthesis of the three monopyridinium oximes and evaluation of their potency to reactivate acetylcholinesterase inhibited by nerve agents. J Appl Biomed. 2004;2(1):51-56.
Download citation

References

  1. Bajgar J.: The influence of inhibitors and other factors on cholinesterases. Sb. Věd. Prací LFUK (Hradec Králové) 34: 3-77, 1994.
  2. Bielavský J., J. Kassa, I. Elsnerová, L. Dejmek: Cholinesterase reactivators derived from pyridine-2-carbaldoxime. Coll. Czech. Chem. Commun. 63: 199-204, 1997. Go to original source...
  3. Cabal J.: A comparison of the features of the esters of dialkylamidofluorophosphate acids with other fluorophosphates (In Czech). Voj. Zdrav. Listy 5/6: 215-221, 1992.
  4. Cabal J. and J. Bajgar: Tabun - reappearance 50 years later (In Czech). Chem. Listy 93:27-31, 1999..
  5. Daroszewski J., B. Serafin, G. Borkowska, S. Rump: Potential acetylcholinesterase reactivators, pyridine and a-oxooxime derivatives. Pharmazie 41:699-702, 1986. Go to original source... Go to PubMed...
  6. Ginsburg S. and I.B. Wilson: Oxime of pyridine series. J. Am. Chem. Soc. 79: 481-483, 1957. Go to original source...
  7. Hampl F., J. Mazáč, F. Liška, J. Šrogl, L. Kábrt, M. Suchánek: Quarternary heteroarenium aldoximes as catalysts for cleveage of phosphate esters. Collect Czech. Chem. Commun. 60: 883-893, 1995. Go to original source...
  8. Kassa J. and J. Bajgar: Comparison of the efficacy of HI-6 and obidoxime against cyclohexyl methylphosphonofluoridate (GF) in rats. Hum. Exp. Toxicol. 14: 923-928, 1995. Go to original source... Go to PubMed...
  9. Kassa J.and J. Cabal: A comparison of the efficacy of acetylcholinesterase reactivators against cyclohexyl methylphosphonofluoridate (GF agent) by in vitro and in vivo methods. Pharmacol. Toxicol. 84: 41-45, 1999a. Go to original source... Go to PubMed...
  10. Kassa J. and J. Cabal: A comparison of the efficacy of a new asymmetric bispyridinium oxime BI-6 with presently used oximes and H oximes against sarin by in vitro and in vivo methods. Human Exp. Toxicol. 18: 560-565, 1999b. Go to original source... Go to PubMed...
  11. Kassa J.: Review of oximes in the antidotal treatment of poisoning by organophosphorus nerve agents. J. Toxicol. Clin. Toxicol. 40: 803-816, 2002. Go to original source... Go to PubMed...
  12. Kuča K. and J. Cabal: Reactivation of cyclosarin - inhibited acetylcholinesterase (In Czech). Chem. Listy 11:951, 2002.
  13. Kuča K., J. Bielavský, J. Cabal, M. Bielavská: Synthesis of a potential reactivator of acetylcholinesterase 1-(4-hydroxyiminomethylpyridinium)-3-(carbamoylpyridinium)-propane dibromide. Tetrahedron Lett. 44: 3123-3125, 2003a. Go to original source...
  14. Kuča K. and J. Kassa: A Comparison of the ability of a new bispyridinium oxime -1-(4-hydroxyiminomethylpyridinium)-4-(4-carbamoyl-pyridinium)butane dibromide and curr ently used oximes to reactivate nerve agent-inhibited rat brain acetylcholinesterase by in vitro ethods. J. Enz. Inhibition (In Press), 2003b. Go to original source... Go to PubMed...
  15. Maekawa K.: The sarin poisoning incident in Tokyo subway. Oral presentation, The fift International Symposium on Protection Against CBWA, Stockholm, June 11-16, 1995.
  16. Marrs T.C.: Organophosphate poisoning. Pharmacol. Therap. 58: 51-66, 1993. Go to original source... Go to PubMed...
  17. Patočka J., J. Bielavský, F. Ornst: Reactivating effect of alpha, omega-bis-(4-pyridinealdoxime)-2-trans-butene dibromide on isopropylmethylphosphonylated acetylcholinesterase. FEBS Lett. 10: 182-184, 1970. Go to original source... Go to PubMed...
  18. Petrova I. and J. Bielavský: An overview of syntheses of cholinesterase reactivators from 1980 to 1992 (In Czech). Voj. Zdrav. Listy 70: 63-73, 2001.
  19. Taylor P.: Anticholinergic agents. In: The Pharmacological Basis of Therapeutics. McGraw Hill, New York 1996, pp. 161.
  20. Thiermann H., L. Szinicz, F. Eyer, F. Worek, P. Eyer, N. Felgenhauer, T. Zilker: Modern strategies in therapy of organophosphate poisoning. Toxicol. Lett. 107: 233-239, 1999. Go to original source... Go to PubMed...
  21. Wilson I.B. and F. Sondheimer: A specific antidote against lethal alkyl phosphate intoxication. V. Antidotal properties. Arch. Biochem. Biophys. 69:468-474, 1957. Go to original source... Go to PubMed...
  22. Worek F., R. Widmann, O. Knopff, L. Szinicz: Reactivating potency of obidoxime, pralidoxime, HI-6 and Hlo-7 in human erythrocyte acetylcholinesterase inhibited by highly toxic organophosphorus compound. Arch. Toxicol. 72: 237-243, 1998. Go to original source... Go to PubMed...
  23. Worek F., C. Diepold, P. Eyer: Dimethylphosphoryl-inhibited human cholinesterases: inhibition, reactivation, and aging kinetics. Arch. Toxicol. 73: 7-14, 1999. Go to original source... Go to PubMed...